Strengthening Aqsens Health’s board with diagnostics market expertise

Aqsens Health News, Strengthening Aqsens Health’s board with diagnostics market expertise, July 2nd 2024

Aqsens Health is delighted to announce changes in its Board of Directors. The Dean of the Faculty of Medicine at the University of Turku and Aqsens Health co-founder Pekka Hänninen assumes the leadership role as the Chairman of the Board of Directors.

We are also thrilled to welcome Paul Eros to the board. His extensive experience in the in-vitro diagnostics industry and expertise in executive management will be invaluable assets as Aqsens Health continues its growth.

At the same time we want to express our deep appreciation to Aaron Michelin, whose dedication and leadership on the board have been instrumental in shaping our company's early stages. We’re happy to continue working together with Mr. Michelin also in the future.

The new composition of the board reflects our commitment to an experienced medtech team that can drive innovation and growth. We're excited about the future and confident in the new leadership's ability to guide us towards our strategic vision.

Stay up to date on our projects and company news by following us on LinkedIn

Related posts:

Mr. Paul Eros brings over 25 years of executive experience in diagnostics to Aqsens Health as a Senior Business Advisor

Aqsens Health’s board of directors strengthened with medtech industry expertise – An interview with Tuomo Pätsi

Previous
Previous

Executing an impactful urinary tract cancers strategy – when opportunity grabs you by the hand

Next
Next

What are Phages? – A look into their history and applications